APA (7th ed.) Citation

Wang, S., Thomassen, K., Kurch, L., Opitz, S., Franke, G., Bach, E., . . . Kayser, S. (2021). Combination of tagraxofusp and azacitidine is an effective option for relapsed blastic plasmacytoid dendritic cell neoplasm after allogeneic hematopoietic stem-cell transplantation. Clinical lymphoma, myeloma & leukemia, 21(7), . https://doi.org/10.1016/j.clml.2021.02.008

Chicago Style (17th ed.) Citation

Wang, Song-Yau, Katrin Thomassen, Lars Kurch, Sabine Opitz, Georg-Nikolaus Franke, Enrica Bach, Uwe Platzbecker, and Sabine Kayser. "Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-cell Transplantation." Clinical Lymphoma, Myeloma & Leukemia 21, no. 7 (2021). https://doi.org/10.1016/j.clml.2021.02.008.

MLA (9th ed.) Citation

Wang, Song-Yau, et al. "Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-cell Transplantation." Clinical Lymphoma, Myeloma & Leukemia, vol. 21, no. 7, 2021, https://doi.org/10.1016/j.clml.2021.02.008.